BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23944659)

  • 1. Cancer-free survival of psoriasis patients treated with methotrexate and cyclosporine combination.
    Aydin F; Yuksel EP; Senturk N; Canturk T; Turanli AY
    Cutan Ocul Toxicol; 2014 Sep; 33(3):181-3. PubMed ID: 23944659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F; Canturk T; Senturk N; Turanli AY
    Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center.
    Heinecke GM; Luber AJ; Levitt JO; Lebwohl MG
    J Drugs Dermatol; 2013 Oct; 12(10):1098-102. PubMed ID: 24085044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
    Wald JM; Klufas DM; Strober BE
    J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract]   [Full Text] [Related]  

  • 7. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
    Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA
    N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine.
    Warren RB; Griffiths CE
    Clin Dermatol; 2008; 26(5):438-47. PubMed ID: 18755362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A global approach to psoriatic patients through PASI score and Skindex-29.
    Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
    G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic therapy of psoriasis].
    Altmeyer P; Nüchel C
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
    [No Abstract]   [Full Text] [Related]  

  • 11. Etanercept combined with methotrexate for high-need psoriasis.
    Driessen RJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the use of drugs in patients suffering from psoriasis and their impact on quality of life.
    Karamata VV; Gandhi AM; Patel PP; Sutaria A; Desai MK
    Indian J Pharmacol; 2017; 49(1):84-88. PubMed ID: 28458428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
    Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
    Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased insulin-like growth factor binding protein-3 expression level in psoriatic tissue before and after systemic treatment with cyclosporine A and methotrexate.
    Ozden MG; Ilter N; Suer OE; Solaktekin N; Gürer MA
    Int J Dermatol; 2008 Nov; 47(11):1177-83. PubMed ID: 18986456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic management of psoriasis].
    Guilhou JJ
    Ann Dermatol Venereol; 1996; 123(4):276-9. PubMed ID: 8763756
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases.
    Philipp S; Wilsmann-Theis D; Weyergraf A; Rotterdam S; Frambach Y; Gerdes S; Mössner R
    J Dtsch Dermatol Ges; 2012 Nov; 10(11):821-37. PubMed ID: 22934607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.
    Paul CF; Ho VC; McGeown C; Christophers E; Schmidtmann B; Guillaume JC; Lamarque V; Dubertret L
    J Invest Dermatol; 2003 Feb; 120(2):211-6. PubMed ID: 12542524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases.
    Wilsmann-Theis D; Frambach Y; Philipp S; Weyergraf AJ; Jacobi A; Mössner R; Gerdes S
    Dermatology; 2015; 230(2):119-27. PubMed ID: 25661583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with tumor necrosis factor inhibitors in psoriasis treatment.
    Famenini S; Wu JJ
    Cutis; 2013 Sep; 92(3):140-7. PubMed ID: 24153143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of cyclosporine versus methotrexate in severe psoriasis: a study from north India.
    Sandhu K; Kaur I; Kumar B; Saraswat A
    J Dermatol; 2003 Jun; 30(6):458-63. PubMed ID: 12810993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.